These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3830733)

  • 1. Elevated bioactive prolactin in women at risk for familial breast cancer.
    Love RR; Rose DP
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1553-4. PubMed ID: 3830733
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum interleukin 2 (IL-2) levels and prolactin bioactive/radioimmunoassay ratios of women at risk for breast cancer.
    Gala RR; Martino S; Wiejowski SA; Kresge CL; Alonso MM
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1603-5. PubMed ID: 2591452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
    Love RR; Rose DR; Surawicz TS; Newcomb PA
    Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bioactive lactogenic hormone levels in women with familial breast cancer and their relatives.
    Anderson E; Morten H; Wang DY; Burns P; Birch J; Howell A
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1719-25. PubMed ID: 2632255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive prolactin and the potential for reducing breast cancer risk.
    Rose DP
    Prev Med; 1986 Jan; 15(1):99-101. PubMed ID: 3714664
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma-prolactin in human breast cancer.
    Kwa HG; De Jong-Bakker M; Engelsman E; Cleton FJ
    Lancet; 1974 Mar; 1(7855):433-5. PubMed ID: 4131433
    [No Abstract]   [Full Text] [Related]  

  • 7. Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression.
    Levin PA; Malarkey WB
    J Clin Endocrinol Metab; 1981 Jul; 53(1):179-83. PubMed ID: 7240375
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
    de Waard F; Kwa HG; Poortman J
    Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
    Kwa HG; Wang DY
    Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
    Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
    Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolactin: radioimmunologic levels and changes under ethinyl estradiol and nafoxidine in advanced breast cancers in women].
    Gorins A; Netter A; L'Hermite M
    Ann Endocrinol (Paris); 1973; 34(5):601-2. PubMed ID: 4794619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
    Eliassen AH; Tworoger SS; Hankinson SE
    Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma prolactin in breast cancer.
    Boyns AR; Cole EN; Griffiths K; Roberts MM; Buchan R; Wilson RG; Forrest AP
    Eur J Cancer (1965); 1973 Feb; 9(2):99-102. PubMed ID: 4717492
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma prolactin and its relationship to risk factors in human breast cancer.
    Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
    Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prolactin and breast cancer.
    Wilson RG; Buchan R; Roberts MM; Forrest AP; Boyns AR; Cole EN; Griffiths K
    Cancer; 1974 May; 33(5):1325-7. PubMed ID: 4823482
    [No Abstract]   [Full Text] [Related]  

  • 20. Diet, serum, breast fluid growth hormone, and prolactin levels in normal premenopausal Finnish and American women.
    Rose DP; Boyar AP; Kettunen K
    Nutr Cancer; 1988; 11(3):179-87. PubMed ID: 2841652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.